Denis Chem Lab [DENISCHEM] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Denis Chem Lab Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Denis Chem Lab Ltd. wins in 14 metrics, Sun Pharma Advanced Research Company Ltd. wins in 3 metrics, with 0 ties. Denis Chem Lab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Denis Chem Lab Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 12.26 -13.65 Denis Chem Lab Ltd.
Price-to-Book Ratio 1.22 -13.55 Denis Chem Lab Ltd.
Debt-to-Equity Ratio 0.09 -1.21 Denis Chem Lab Ltd.
PEG Ratio 0.14 -11.15 Denis Chem Lab Ltd.
EV/EBITDA 5.61 -22.27 Denis Chem Lab Ltd.
Profit Margin (TTM) 43.34% -53.22% Denis Chem Lab Ltd.
Operating Margin (TTM) 6.45% -700.71% Denis Chem Lab Ltd.
EBITDA Margin (TTM) 6.45% N/A N/A
Return on Equity 9.49% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 7.19% -102.08% Denis Chem Lab Ltd.
Free Cash Flow (TTM) $44.64M $-3.71B Denis Chem Lab Ltd.
Dividend Yield 4.03% N/A N/A
1-Year Return -29.77% 14.56% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 0.62 87.98 Denis Chem Lab Ltd.
Enterprise Value $1.07B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 0.62 95.73 Denis Chem Lab Ltd.
Gross Profit Margin (TTM) 49.30% -59.53% Denis Chem Lab Ltd.
Revenue per Share (TTM) $125 $2 Denis Chem Lab Ltd.
Earnings per Share (Diluted) $6.28 $-8.25 Denis Chem Lab Ltd.
Beta (Stock Volatility) N/A 0.19 N/A

Denis Chem Lab Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

DENISCHEM
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Denis Chem Lab Ltd.1.96%-4.77%-9.16%-6.26%-17.73%-12.08%
Sun Pharma Advanced Research Company Ltd.2.14%-5.81%49.25%68.87%37.58%54.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Denis Chem Lab Ltd.-29.77%-5.54%9.45%-14.17%216.15%216.15%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Denis Chem Lab Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricDENISCHEMSPARC
Market Information
Market Cap i₹1.07B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,7442,401,062
90 Day Avg. Volume i9,9892,083,443
Last Close₹71.32₹212.97
52 Week Range₹56.10 - ₹109.25₹108.00 - ₹248.75
% from 52W High-34.72%-14.38%
All-Time High₹232.90 (Jun 17, 2024)₹875.00 (Apr 24, 2006)
% from All-Time High-69.38%-75.66%
Growth Metrics
Quarterly Revenue Growth-0.01%-0.43%
Quarterly Earnings Growth0.06%-0.43%
Financial Health
Profit Margin (TTM) i0.43%-0.53%
Operating Margin (TTM) i0.06%-7.01%
Return on Equity (TTM) i0.09%1.58%
Debt to Equity (MRQ) i0.09-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹63.14₹-10.63
Cash per Share (MRQ)N/A₹0.03
Operating Cash Flow (TTM) i₹105.01M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹80.76M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i4.03%N/A
Last 12-Month Dividend i₹4.00N/A

Valuation & Enterprise Metrics Analysis: Denis Chem Lab Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricDENISCHEM (Apr 26, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i12.26-13.65
Forward P/E iN/A2.60
PEG Ratio i0.14-11.15
Price to Sales (TTM) i0.6287.98
Price to Book (MRQ) i1.22-13.55
Market Capitalization
Market Capitalization i₹1.07B₹46.75B
Enterprise Value i₹1.07B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i0.6295.73
Enterprise to EBITDA i5.61-22.27
Risk & Other Metrics
Beta iN/A0.19
Book Value per Share (MRQ) i₹63.14₹-10.63

Financial Statements Comparison: Denis Chem Lab Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDENISCHEM (2025)SPARC (2025)
Revenue/Sales i1.73B717.66M
Cost of Goods Sold i981.93M1.10B
COGS % of Revenue i56.7%153.2%
Gross Profit i751.05M-381.94M
Gross Margin i43.3%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i103.13M-3.34B
Operating Margin i6.0%-465.5%
EBITDA i190.23M-3.23B
EBITDA Margin i11.0%-450.0%
Pre-Tax Income i111.11M-3.43B
Pre-Tax Income % of Revenue i6.4%-477.6%
Income Tax i30.36M-2.72M
Income Tax % of Revenue i1.8%-0.4%
Net Income (Profit) i80.76M-3.43B
Profit Margin i4.7%-477.3%

Balance Sheet & Liquidity Metrics

MetricDENISCHEM (2025)SPARC (2025)
Cash & Equivalents i8.50M19.64M
Total Current Assets i706.45M261.97M
Total Current Assets % of Revenue i40.8%36.5%
Total Current Liabilities i261.73M3.74B
Total Current Liabilities % of Revenue i15.1%521.5%
Long-Term Debt i4.53M1.07B
Long-Term Debt % of Revenue i0.3%149.0%
Total Shareholders Equity i851.04M-2.17B
Retained Earnings i390.31M-23.22B
Retained Earnings % of Revenue i22.5%-3,235.0%
Property, Plant & Equipment i39.91M178.02M

Cash Flow Statement Comparison

MetricDENISCHEM (2025)SPARC (2025)
Operating Cash Flow i105.01M-3.48B
Operating Cash Flow % of Revenue i6.1%-485.5%
Capital Expenditures iN/A-97.45M
Free Cash Flow i44.64M-3.71B
FCF Margin i2.6%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDENISCHEMSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i13.88M324.52M
Float Shares iN/A91.32M
% Held by Insiders i78.40%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i21.60%24.48%

Dividend Analysis & Yield Comparison: Denis Chem Lab Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricDENISCHEMSPARC
Last 12-Month Dividend i₹4.00N/A
Last 12-Month Dividend Yield i4.03%N/A
3-Year Avg Annual Dividend i₹3.67N/A
3-Year Avg Dividend Yield i1.73%N/A
3-Year Total Dividends i₹11.00N/A
Ex-Dividend DateSep 19, 2025N/A